Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2015-09-02
Original SEC Filing: Click here

---

Webplus: CBPO/20150902/8-K/2_EX-10.1/000.htm SEC Original: v419657_ex10-1.htm
Strategic Cooperation Agreement to Source Raw Plasma This Agreement is entered on August 28, 2015 by and between: Party A Party B Party C WHEREAS 1. Party A has certain source plasma inventory for producing blood products. Party A has financial difficulty in keeping the daily operation of its plasma collections stations. 2. Party B has the need for source

---

---

Webplus: CBPO/20150902/8-K/3_EX-99.1/000.htm SEC Original: v419657_ex99-1.htm
FOR RELEASE September 2, 2015 China Biologic Enters into Strategic Collaboration Agreement to Source Raw BEIJING, China – September 2, 2015 – The raw plasma will be shipped in batches to Guizhou Taibang for the production of human albumin and IVIG products. The Company expects that the products made from the sourced raw plasma will begin to reach the market

---

---

Webplus: CBPO/20150902/8-K/1/000.htm SEC Original: v419657_8k.htm

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2015-09-02CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125